Novonix Limited develops and supplies battery materials, equipment, and services to the lithium-ion battery market in North America. More Details
Excellent balance sheet with limited growth.
Share Price & News
How has Novonix's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: GC3's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: GC3 exceeded the German Electronic industry which returned 6.1% over the past year.
Return vs Market: GC3 exceeded the German Market which returned 2.6% over the past year.
Price Volatility Vs. Market
How volatile is Novonix's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Novonix undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate GC3's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate GC3's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: GC3 is unprofitable, so we can't compare its PE Ratio to the DE Electronic industry average.
PE vs Market: GC3 is unprofitable, so we can't compare its PE Ratio to the German market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate GC3's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: GC3 is overvalued based on its PB Ratio (5.4x) compared to the DE Electronic industry average (1.9x).
How is Novonix forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if GC3's forecast earnings growth is above the savings rate (0.2%).
Earnings vs Market: Insufficient data to determine if GC3's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: GC3's revenue (53.4% per year) is forecast to grow faster than the German market (6.2% per year).
High Growth Revenue: GC3's revenue (53.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GC3's Return on Equity is forecast to be low in 3 years time (14%).
How has Novonix performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GC3 is currently unprofitable.
Growing Profit Margin: GC3 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: GC3 is unprofitable, and losses have increased over the past 5 years at a rate of 54.9% per year.
Accelerating Growth: Unable to compare GC3's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GC3 is unprofitable, making it difficult to compare its past year earnings growth to the Electronic industry (-42.2%).
Return on Equity
High ROE: GC3 has a negative Return on Equity (-30.1%), as it is currently unprofitable.
How is Novonix's financial position?
Financial Position Analysis
Short Term Liabilities: GC3's short term assets (A$41.4M) exceed its short term liabilities (A$4.0M).
Long Term Liabilities: GC3's short term assets (A$41.4M) exceed its long term liabilities (A$4.7M).
Debt to Equity History and Analysis
Debt Level: GC3's debt to equity ratio (3.3%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if GC3's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GC3 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: GC3 has sufficient cash runway for 2.7 years if free cash flow continues to reduce at historical rates of 43.6% each year.
What is Novonix current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate GC3's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate GC3's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if GC3's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if GC3's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of GC3's dividend in 3 years as they are not forecast to pay a notable one for the German market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Dr. John Christopher Burns, also known as Chris, serves as Group Chief Executive Officer of Novonix Limited since September 2020 and has been its Chief Operating Officer. He has been Chief Executive Office ...
CEO Compensation Analysis
Compensation vs Market: Chris's total compensation ($USD1.80M) is above average for companies of similar size in the German market ($USD735.04K).
Compensation vs Earnings: Chris's compensation has increased whilst the company is unprofitable.
|Non-Executive Director||8.42yrs||AU$572.13k||8.53% |
|Executive Director||3.17yrs||AU$377.54k||0.43% |
|Independent Non-Executive Director||2.17yrs||AU$2.77m||1.18% |
|Independent Non-Executive Chairman||5.08yrs||AU$383.57k||0.61% |
|Independent Non-Executive Director||no data||no data||0.20% |
|Independent Non-Executive Director||3.92yrs||AU$33.46k||0.15% |
Experienced Board: GC3's board of directors are considered experienced (3.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 174.4%.
Novonix Limited's company bio, employee growth, exchange listings and data sources
- Name: Novonix Limited
- Ticker: GC3
- Exchange: DB
- Founded: 2012
- Industry: Electronic Equipment and Instruments
- Sector: Tech
- Market Cap: AU$365.680m
- Listing Market Cap: AU$221.421m
- Shares outstanding: 351.62m
- Website: https://www.novonixgroup.com
- Novonix Limited
- 46 Edward Street
- Level 8
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|NVX||ASX (Australian Securities Exchange)||Yes||Common Stock||AU||AUD||Dec 2015|
|NVX||CHIA (Chi-X Australia)||Yes||Common Stock||AU||AUD||Dec 2015|
|GC3||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Dec 2015|
|NVNX.F||OTCPK (Pink Sheets LLC)||Yes||Common Stock||US||USD||Dec 2015|
Novonix Limited develops and supplies battery materials, equipment, and services to the lithium-ion battery market in North America. The company operates through three segments: Graphite Exploration and Mi ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/28 20:47|
|End of Day Share Price||2020/09/28 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.